PriceTargets.com logo

Premier Health of America - PHA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$1.00
  • Forecasted Upside: 115.05%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$0.47 As of 04/29/2024 03:47 PM ET
▼ -0.015 (-3.13%)

This chart shows the closing price for PHA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Premier Health of America Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHA

Analyst Price Target is C$1.00
▲ +115.05% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Premier Health of America in the last 3 months. The average price target is C$1.00, with a high forecast of C$1.00 and a low forecast of C$1.00. The average price target represents a 115.05% upside from the last price of C$0.47.

This chart shows the closing price for PHA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Premier Health of America. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/31/2024Leede Jones GabReiterated RatingBuy
8/28/2023Acumen CapitalBoost TargetBuyC$0.95 ➝ C$1.00
(Data available from 4/29/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/2/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/1/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/1/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/31/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/29/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Premier Health of America

Premier Health of America Inc., together with its subsidiaries, engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada. It operates in two segments, Per Diem and Travel Nurse. The company provides temporary or permanent resources, including registered nurses, registered practical nurses, registered therapists, and personal support workers for public and private hospitals, medical clinics, and retirement homes. It also offers health consulting, nursing, and healthcare services in remote communities, as well as provides nursing and assistance services in remote regions; and Code Bleu, an agency to employ staff nurses. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company is headquartered in Blainville, Canada.
Read More

Today's Range

Now: C$0.47
Low: C$0.46
High: C$0.52

50 Day Range

MA: C$0.52
Low: C$0.47
High: C$0.67

52 Week Range

Now: C$0.47
Low: C$0.23
High: C$0.67

Volume

116,000 shs

Average Volume

33,241 shs

Market Capitalization

C$25.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Premier Health of America?

The following Wall Street research analysts have issued reports on Premier Health of America in the last year: Acumen Capital, and Leede Jones Gab.
View the latest analyst ratings for PHA.

What is the current price target for Premier Health of America?

1 Wall Street analysts have set twelve-month price targets for Premier Health of America in the last year. Their average twelve-month price target is C$1.00, suggesting a possible upside of 115.1%. Acumen Capital has the highest price target set, predicting PHA will reach C$1.00 in the next twelve months. Acumen Capital has the lowest price target set, forecasting a price of C$1.00 for Premier Health of America in the next year.
View the latest price targets for PHA.

What is the current consensus analyst rating for Premier Health of America?

Premier Health of America currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHA will outperform the market and that investors should add to their positions of Premier Health of America.
View the latest ratings for PHA.

What other companies compete with Premier Health of America?

Other companies that are similar to Premier Health of America include Nova Leap Health, KDA Group, Aptose Biosciences, Acasti Pharma and GeneNews. Learn More about companies similar to Premier Health of America.

How do I contact Premier Health of America's investor relations team?

Premier Health of America's physical mailing address is 1114 CurE-Labelle Boulevard, Suite 1, Blainville, QC J7C 2M9, Canada, . The company's listed phone number is 800-231-9916. The official website for Premier Health of America is www.premierhealthgroup.ca. Learn More about contacing Premier Health of America investor relations.